在心力衰竭中肌肉心脏再血管化,减少排气分数
Deutsches Arzteblatt international
|January 16, 2025
概括
以指导方针为导向的医疗疗显著改善了心力衰竭的存活率,减少了喷射率 (HFrEF) 的患者. 冠状动脉旁路移植 (CABG) 可能为患有严重冠状动脉疾病的HFrEF患者提供长期益处.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
- 心脏衰竭研究研究
背景情况:
- 降低射出率心力衰竭 (HFrEF) 患者越来越多地面临非心血管死亡率.
- 心肌复血管化 (PCI或CABG) 对缺血性心肌病的HFrEF患者的长期影响尚不清楚.
研究的目的:
- 审查目前关于HFrEF和缺血性心肌病患者肌肉组织再血管化的长期结果的证据.
- 在现代药物治疗HFrEF的背景下评估重血管化程序的作用.
主要方法:
- 对相关的临床研究和当前的指导方针进行了选择性的文献搜索.
- 分析随机对照试验的数据,包括STICH试验,以及对HF药物治疗的比较研究.
主要成果:
- 对HFrEF的药物治疗显著增加了患者的生存时间,在55岁的患者中平均增加了8.3年.
- 冠状动脉旁路移植 (CABG) 在患有严重冠状动脉疾病的HFrEF患者中与单独的医疗治疗相比,显示出长期生存益处 (STICH试验:所有原因死亡的HR 0.84).
- 没有随机对照试验直接比较CABG和皮肤穿透冠状动脉干预 (PCI).
结论:
- 在HFrEF患者的长期生存中,最佳的指导方针导向的医疗治疗至关重要.
- 心肌再血管化的决定应涉及跨学科的心脏团队,考虑患者特异性因素和当前的医疗治疗.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.4K
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
11.9K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K